Eutilex.Co.Ltd (263050) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.083x

Based on the latest financial reports, Eutilex.Co.Ltd (263050) has a cash flow conversion efficiency ratio of -0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.41 Billion ≈ $-1.63 Million USD) by net assets (₩28.91 Billion ≈ $19.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Eutilex.Co.Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Eutilex.Co.Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Eutilex.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Eutilex.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eutilex.Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Conduril - Engenharia S.A LS:CDU	N/A
Trend Gayrimenkul Yatirim Ortakligi AS IS:TDGYO	0.222x
OYAK Yatirim Ortakligi AS IS:OYAYO	-0.012x
Mitie Group PLC LSE:MTO	0.290x
WITTED MEGACORP OYJ EO 1 F:8OS	0.106x
Nexus Minerals Ltd AU:NXM	-0.347x
Smartiks Yazilim AS IS:SMART	0.098x
Rig Tenders Tbk JK:RIGS	0.040x

Annual Cash Flow Conversion Efficiency for Eutilex.Co.Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Eutilex.Co.Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Eutilex.Co.Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩39.94 Billion ≈ $27.07 Million	₩-21.40 Billion ≈ $-14.50 Million	-0.536x	-26.63%
2023-12-31	₩60.44 Billion ≈ $40.96 Million	₩-25.58 Billion ≈ $-17.33 Million	-0.423x	-24.17%
2022-12-31	₩87.75 Billion ≈ $59.47 Million	₩-29.90 Billion ≈ $-20.26 Million	-0.341x	+13.88%
2021-12-31	₩68.38 Billion ≈ $46.34 Million	₩-27.06 Billion ≈ $-18.34 Million	-0.396x	-30.05%
2020-12-31	₩58.51 Billion ≈ $39.65 Million	₩-17.80 Billion ≈ $-12.07 Million	-0.304x	-42.14%
2019-12-31	₩62.83 Billion ≈ $42.58 Million	₩-13.45 Billion ≈ $-9.11 Million	-0.214x	-62.31%
2018-12-31	₩77.49 Billion ≈ $52.52 Million	₩-10.22 Billion ≈ $-6.93 Million	-0.132x	-24.07%
2017-12-31	₩51.13 Billion ≈ $34.65 Million	₩-5.44 Billion ≈ $-3.68 Million	-0.106x	+25.20%
2016-12-31	₩25.87 Billion ≈ $17.53 Million	₩-3.68 Billion ≈ $-2.49 Million	-0.142x	--

About Eutilex.Co.Ltd

KQ:263050 Korea Biotechnology

Market Cap

$23.94 Million

₩35.32 Billion KRW

Market Cap Rank

#24551 Global

#1737 in Korea

Share Price

₩959.00

Change (1 day)

+29.95%

52-Week Range

₩683.00 - ₩2740.00

All Time High

₩41553.86